Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

ClinicalTrials.gov ID: NCT04784091

Public ClinicalTrials.gov record NCT04784091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

Study identification

NCT ID
NCT04784091
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Tarsus Pharmaceuticals, Inc.
Industry
Enrollment
412 participants

Conditions and interventions

Conditions

Interventions

  • TP-03 Drug
  • TP-03 Vehicle Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2021
Primary completion
May 8, 2022
Completion
May 8, 2022
Last update posted
Dec 20, 2023

2021 – 2022

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Global Retina Institute Scottsdale Arizona 85254
Shultz Chang Vision Northridge California 91325
East Bay Eye Center San Ramon California 94583
Vision Institute Colorado Springs Colorado 80907
Pinnacle Research Institute Fort Lauderdale Florida 33309
Jackson Eye, S.C. Lake Villa Illinois 60046
Pankratz Eye Institute Columbus Indiana 47203
Michael Washburn Center for Ophthalmic Research LLC Indianapolis Indiana 46113
Kannarr Eye Care Pittsburg Kansas 66762
The Eye Care Institute Louisville Kentucky 40206
Complete Eye Care of Medina Medina Minnesota 55340
Tauber Eye Center Kansas City Missouri 64111
Ophthalmology Associates St Louis Missouri 63131
NC Eye Associates Apex North Carolina 27502
Pure Ophthalmic Research Mint Hill North Carolina 28227
Vita Eye Clinic Shelby North Carolina 28150
Northern Ophthalmic Associates Jenkintown Pennsylvania 19046
Alpine Research Organization / Healthy Heart Clinics of America Clinton Utah 84015
Alpine Research Organization Inc./ Country Hills Eye Center Ogden Utah 84403
Periman Eye Institute Seattle Washington 98119
New River Vision Care Oak Hill West Virginia 25901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04784091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04784091 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →